| Virus‐like particles: Next‐generation nanoparticles for targeted therapeutic delivery MJ Rohovie, M Nagasawa, JR Swartz Bioengineering & translational medicine 2 (1), 43-57, 2017 | 343 | 2017 |
| Arl8/ARL-8 functions in apoptotic cell removal by mediating phagolysosome formation in Caenorhabditis elegans A Sasaki, I Nakae, M Nagasawa, K Hashimoto, F Abe, K Saito, ... Molecular biology of the cell 24 (10), 1584-1592, 2013 | 47 | 2013 |
| Virus-like particles: next-generation nanoparticles for targeted therapeutic delivery. Bioeng. Transl. Med. 2, 43–57 MJ Rohovie, M Nagasawa, JR Swartz Wiley Online Library, 2017 | 5 | 2017 |
| Engineered hepatitis b core polypeptide JR Swartz, R Mathew, MJ Rohovie, M Nagasawa US Patent App. 17/581,655, 2022 | | 2022 |
| Engineered cd47 extracellular domain for bioconjugation JR Swartz, M Nagasawa US Patent App. 17/435,325, 2022 | | 2022 |
| Engineered hepatitis B core polypeptide JR Swartz, R Mathew, MJ Rohovie, M Nagasawa US Patent 11,261,216, 2022 | | 2022 |
| Home Visit Rehabilitation Based on the Philosophy of Community Rehabilitation-House Renovation and Use of Assistive Devices Lead to Participation in Society M Nagasawa, K Saito, H Wakabayashi, A Hakuno Gan to Kagaku ryoho. Cancer & Chemotherapy 46 (Suppl 1), 52-54, 2019 | | 2019 |
| Engineering Virus-like Particles for Targeted Delivery of Anti-cancer Drugs M Nagasawa Stanford University, 2019 | | 2019 |
| Evolution of a modular, multi-functional targeted delivery nanoparticle J Swartz, M Rohovie, R Mathew, M Nagasawa | | 2019 |
| Arl8/ARL-8 functions in apoptotic cell removal by mediating phagolysosome formation in C. elegans A Sasaki, I Nakae, M Nagasawa, K Hashimoto, F Abe, K Saito, ... Molecular Biology of the Cell, 2012 | | 2012 |
